Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of October 2015, with the report signed on November 10, 2015. The filing is a compliance report pursuant to Article 11 of CVM Instruction # 358/2002, detailing transactions involving the company's own securities and derivatives. It is not a financial results report for the fiscal year ending December 31, 2015.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it reports on treasury share and ADR activity:
- Treasury Shares (Initial Balance): 37,545,695 shares (0.2389% of total shares).
- Treasury Shares (Final Balance): 36,374,189 shares (0.2314% of total shares).
- ADR Holdings: 0 (Initial and Final Balance).
- Total Volume of Sales (Treasury Shares): 1,333,145 shares for R$ 5,528,781.84.
- Total Volume of Purchases (Treasury Shares): 278,114 shares for R$ 5,528,942.90.
- ADR Conversion: 116,475 ADRs converted to common shares.
Material Changes
The primary material change reported is the net reduction in the company's treasury share holdings. The company sold 1,333,145 shares (primarily via option exercises) and purchased 278,114 shares (via a share acquisition plan), resulting in a net decrease of 1,055,031 treasury shares. Additionally, 116,475 ADRs were converted into common shares and subsequently sold.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, or contingencies. The document is strictly a regulatory disclosure of specific securities transactions.
Important Facts for Investors to Verify
- Verify the impact of the net reduction in treasury shares on the company's total outstanding share count and potential dilution.
- Confirm the pricing of the share acquisition plan purchases (approx. R$ 19.89 - R$ 20.00) against the market price during October 2015.
- Note that this filing does not contain Q3 or full-year 2015 financial results; investors should refer to the Form 20-F or quarterly reports for operational data.
- Verify the specific terms of the options exercised, as prices ranged significantly from R$ 0.49 to R$ 8.72.